Emotional impact of chemotherapy-induced alopecia: a qualitative phenomenological study on adult cancer patients.
Article Sidebar
Main Article Content
Abstract
Introduction
chemotherapy-induced alopecia (CIA) has a negative emotional impact on patients as it is experienced as a deterioration of one's body image and a clear sign of the disease in progress.
Objectives
this study aims to understand the experiences and emotions felt by people in oncological follow-up who have suffered from chemotherapy-induced alopecia.
Materials and methods
a qualitative phenomenological study was conducted through semi-structured interviews on a convenience sampling of adult cancer patients from June to December 2022. Analysis was carried out by two experts using the Colaizzi method.
Results
12 interviews were carried out from which 4 main themes emerged: (I) emotions experienced by patients after hair loss; (II) alteration of self-perception regarding physical appearance; (III) relationship with others and interpersonal dynamics; (IV) the closest people during changes in personal identity and body image where multidisciplinary educational and emotional support are highlighted.
Discussion and Conclusions
results are consistent with scientific literature and highlight a discomfort due to CIA negatively associated with body image and self psycho-social well-being. Health workers must acquire awareness of the extent of the distress for educational interventions aimed at developing effective coping strategies.
Downloads
Article Details
The authors agree to transfer the right of their publication to the Journal, simultaneously licensed under a Creative Commons License - Attribution that allows others to share the work indicating intellectual authorship and the first publication in this magazine.
References
[2] Boland V, Brady AM, Drury A. The physical, psychological and social experiences of alopecia among women re-ceiving chemotherapy: An integrative literature review. Eur J Oncol Nurs. 2020 Dec; 49:101840.
[3] Boland V, Brady AM, Drury A. The physical, psychological, and social experiences of alopecia among women re-ceiving chemotherapy: An integrative literature review. Eur J Oncol Nurs. 2020 Dec; 49:101840.
[4] Smith K, Winstanley J, Boyle F, O'Reilly A, White M, Antill YC. Madarosis: a qualitative study to assess percep-tions and experience of Australian patients with early breast cancer treated with taxane-based chemotherapy. Support Care Cancer. 2018 Feb; 26(2):483-489.
[5] Kruse M, Abraham J. Management of chemotherapy-induced alopecia with scalp cooling. J Oncol Pract. 2018 Mar; 14(3):149-15
[6] Rossi A, Fortuna MC, Caro G, Pranteda G, Garelli V, Pompili U, Carlesimo M. Chemotherapy-induced alopecia man-agement: Clinical experience and practical advice. J Cosmet Dermatol. 2017 Dec 16(4):537-541.
[7] Chon SY, Champion RW, Geddes ER, Rashid RM, Chemotherapy-induced alopeciaJ. Am. Acad. Dermatol., 67 (1) (2012), pp. e37-e47
[8] Trusson D, Pilnick A. The role of hair loss in cancer identity: perceptions of chemotherapy-induced alopecia among women treated for early-stage breast cancer or ductal carcinoma in situ. Cancer Nurs. 2017 Mar/Apr; 40(2): E9-E16.
[9] Zannini L, Verderame F, Cucchiara G, Zinna B, Alba A, Ferrara M. 'My wig has been my journey's companion': perceived effects of an aesthetic care programme for Italian women suffering from chemotherapy-induced alope-cia. Eur J Cancer Care (Engl). 2012 Sep; 21(5):650-60.
[10] Trüeb RM. Chemotherapy-induced hair loss. Skin Therapy Lett. 2010 Jul-Aug; 15(7):5-7.
[11] Cho J, Choi EK, Kim IR, Im YH, Park YH, Lee S, et al. Development and validation of chemotherapy-induced alo-pecia distress scale (CADS) for breast cancer patients. Ann Oncol. 2014; 25:346–51.
[12] Lemieux J, Maunsell E, Provencher L. Chemotherapy-induced alopecia and effects on quality of life among women with breast cancer: A literature review. Psychooncology. 2008; 17:317–28.
[13] Hesketh PJ, Batchelor D, Golant M et al. Chemotherapy‐induced alopecia: Psychosocial impact and therapeutic approaches. Support Care Cancer 2004; 12:543–549.
[14] Dua P,Heilkand MF, Kracen AC, DeshieldsTL, Cancer-relatedhair-loss: a selective review of the alopecia research literature. Psychooncology.2017 Apr; 26(4):438-443.
[15] Van Alphen K, Versluis A, Dercksen W, de Haas H, Lugtenberg R, Tiemensma J, Kroep J, Broadbent E, Kaptein AA, van den Hurk C. Giving A Face to Chemotherapy-Induced Alopecia: A Feasibility Study on Drawings by Patients. Asia Pac J Oncol Nurs. 2020 Mar 30; 7(2):218-224.
[16] Dunnill CJ, Al-Tameemi W, Collett A, Haslam IS, Georgopoulos NT. A clinical and biological guide for understand-ing chemiotherapy-Induced alopecia and its prevention. Oncologist. 2018 Jan; 23(1):84-96.
[17] Erol O, Can G, Aydıner A. Effects of alopecia on body image and quality of life of Turkish cancer women with or without headscarf. Support Care Cancer. 2012 Oct;20(10):2349-56.
[18] Nozawa K, Tomita M, Takahashi E, Toma S, Arai Y, Takahashi M. Distress from changes in physical appearance and support through information provision in male cancer patients. Jpn J Clin Oncol. 2017 Aug 1;47(8):720-727.
[19] Wikramanayake TC, Haberland NI, Akhundlu A, Laboy Nieves A, Miteva M. Prevention and Treatment of Chemo-therapy-Induced Alopecia: What Is Available and What Is Coming? Curr Oncol. 2023 Mar 25;30(4):3609-3626.
[20] Freites-Martinez, A.; Shapiro, J.; Goldfarb, S.; Nangia, J.; Jimenez, J.J.; Paus, R.; Lacouture, M.E. Hair disor-ders in patients with cancer. J. Am. Acad. Dermatol. 2019, 80, 1179–1196
[21] Özüsağlam E, Can G. The impact of the perception of chemotherapy-induced alopecia on psychosocial life. Flor-ence Nightingale J Nurs. 2021 Oct; 29(3):361-370.
[22] Haque E, Alabdaljabar MS, Ruddy KJ, Haddad TC, Thompson CA, Lehman JS, Hashmi SK. Management of chemo-therapy-induced alopecia (CIA): A comprehensive review and future directions. Crit Rev Oncol Hematol. 2020 Dec; 156:103093.
[23] Versluis A, van Alphen K, Dercksen W, de Haas H, van den Hurk C, Kaptein AA. "Dear hair loss"-illness percep-tions of female patients with chemotherapy-induced alopecia. Support Care Cancer. 2022 May; 30(5):3955-3963.
[24] Nozawa K, Toma S, Shimizu C. Distress and impacts on daily life from appearance changes due to cancer treat-ment: A survey of 1,034 patients in Japan. Glob Health Med. 2023 Feb 28; 5(1):54-61.
[25] Choi EK, Kim IR, Chang O, Kang D, Nam SJ, Lee JE, Lee SK, Im YH, Park YH, Yang JH, Cho J. Impact of chemo-therapy-induced alopecia distress on body image, psychosocial well-being, and depression in breast cancer pa-tients. Psychooncology. 2014 Oct;23(10):1103-10.
[26] Mulders M, Vingerhoets A, Bredd W. The impact of cancer and chemothetherapy: percentual similarities and dif-ferences between cancer patients, nurses and physicians. Eur J Oncol Nurs. 2008 Apr; 12(2):97-102.
[27] Paterson C, Kozlovskaia M, Turner M, Strickland K, Roberts C, Ogilvie R, Pranavan G, Craft P. Identifying the sup-portive care needs of men and women affected by chemotherapy-induced alopecia? A systematic review. J Can-cer Surviv. 2021 Feb; 15(1):14-28